Baron Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$400K Sell
759
-1
-0.1% -$561 0.1% 146
2026
Q1
$427K Hold
760
0.13% 131
2025
Q4
$514K Buy
760
+2
+0.3% +$1.36K 0.16% 97
2025
Q3
$484K Sell
758
-9
-1% -$5.46K 0.16% 91
2025
Q2
$411K Sell
767
-83
-10% -$39.7K 0.15% 99
2025
Q1
$357K Sell
850
-114
-12% -$49.5K 0.16% 102
2024
Q4
$399K Buy
964
+41
+4% +$18K 0.19% 86
2024
Q3
$466K Sell
923
-11
-1% -$5.34K 0.22% 70
2024
Q2
$455K Hold
934
0.24% 64
2024
Q1
$504K Sell
934
-1
-0.1% -$546 0.27% 55
2023
Q4
$519K Hold
935
0.28% 48
2023
Q3
$409K Buy
935
+11
+1% +$5.49K 0.26% 58
2023
Q2
$464K Buy
924
+4
+0.4% +$1.92K 0.29% 55
2023
Q1
$460K Buy
920
+8
+0.9% +$3.83K 0.33% 52
2022
Q4
$372K Buy
+912
New +$354K 0.29% 64

Other funds holding IDXX

Baron Wealth Management's IDXX Position: Q2 2026 in Review

Baron Wealth Management reduced its Idexx Laboratories (IDXX) stake by 0.13% in Q2 2026, selling an estimated $561 and leaving 759 shares worth $400K. The position accounts for 0.1% of the portfolio, ranked #146.

Baron Wealth Management first reported a position in IDXX in Q4 2022 and has held it in 15 quarters since. The position peaked at $519K in Q4 2023. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Baron Wealth Management held 759 shares of Idexx Laboratories worth $400K as of Q2 2026.
  • Baron Wealth Management sold 1 Idexx Laboratories share in Q2 2026, an estimated $561.
  • Idexx Laboratories made up 0.1% of Baron Wealth Management's portfolio in Q2 2026, its #146 holding.
  • Baron Wealth Management first reported a position in Idexx Laboratories in Q4 2022 and has held it in 15 quarters since.
  • Baron Wealth Management's Idexx Laboratories position peaked at $519K in Q4 2023.
  • 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Baron Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.